Sage Bionetworks, Merck & Co Collaborate For Integrative Genomics Research Program
Sage and Merck are expected to collaborate to create network-based computational models of disease that will contribute to Merck’s drug development strategy. Merck is expected to provide financial
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.